One type of biotech I pursue is fertility biotech for humans and nonhuman animals. I’ll keep on pursuing the fertility biotech that I envision over the next multiple decades, along with the other biotechnologies that I envision, and see what happens.
A woman has about 10 to 12 years of safe reproductive period, between age 18 and 28 to 30. If you search on the Internet “When pregnancy gets risky for women? “, it’ll say pregnancy is risky for women at or before age 17, and at or after age 35.
So, the safe window of procreation for human female is 12 years at max, or 15 years if you really push it and risk either the life of the woman, the genetic defects in the offspring, or both. I think that is too short. When humans lived until age 35, 12 years of procreation for women were more than enough.
But with humans living beyond age 85, and humans living beyond age 150 in the future through using the human longevity biotech, 12 years of procreation window for women are too short, in my view.
A quick advertisement before I continue on this topic. You can invest in my startup company with as little as US$100, for supporting advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech. Visit Robocentric.com/Investors to invest in my startup.
I’ve a multidecadal commitment to advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech. To learn more about my cause, check out my books, which are available at Robocentric.com/Checkout, Amazon, Apple Books, Spotify, and other online audiobook retailers. Now, back to the main content.
It doesn’t make sense for women to live 50 or more years of her life being unable to procreate, between age 35 and 85 or beyond.
So, in tandem with pursuing developing human longevity biotech, I also pursue developing human fertility duration lengthening biotech, especially for women.
I think the advances in human body biotech should lengthen the fertility duration of women, to 100 years and beyond.
Of course, it doesn’t mean every woman should procreate every year for 100 years in the future, but every woman should have the option to procreate for 100 years or more through the advances in biotech. That’s my view, and that’s one thing I pursue in advancing biotech.
If and when humanity massively expands into outer space via the advances in nuclear-fusion powered outer space tech, when humans must populate other life-supporting planets and artificial mass-scale outer space human habitats, women being able to procreate for 100 years or more will make a lot of sense.
Also, I’ll keep on pursuing increasing growth speed, reducing procreation cycle, and lengthening fertility duration for human-food animals and lab research animals such as chimpanzees, for rapidly producing the nonhuman animals that are beneficial to humans.
The ultimate function or role of a technology is to make what was once scarce abundant. Both human and nonhuman procreation has been relatively scarce and expensive; advances in biotech must make human and nonhuman procreation much more abundant than ever before, both on Earth and in outer space.
You can invest in my startup company with as little as US$100, for supporting advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech. Visit Robocentric.com/Investors to invest in my startup.
My books on advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech are available at Robocentric.com/Checkout, Amazon, Apple Books, Spotify, Google Play Store, and other online audiobook retailers.
I am Allen Young; I’m an Asian-American man who focuses on advancing AI, robotics, human longevity biotech, and nuclear-fusion powered outer space tech.